title: Asthma research in China: a five-year review.
abstract: Asthma is one of the most common chronic diseases worldwide with increasing morbidity. China has the largest asthmatic population and is one of the countries with the highest asthma mortality. Fortunately, asthma research in China, both clinical and scientific, has developed markedly over the past few years. This has resulted in significant increases in our understanding of Chinese asthma prevalence, risk factors, control status, pathogenesis, and new prevention or treatment strategies. In this review, the major achievements of asthma research in China from 2008 to 2012 are summarized.
authors.affiliation: Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
authors.forename: Zhi-Hua
authors.initials: ZH
authors.lastname: Chen
authors.forename: Ping-Li
authors.initials: PL
authors.lastname: Wang
authors.forename: Hua-Hao
authors.initials: HH
authors.lastname: Shen
mesh_terms: D001249:Asthma / Q000453:epidemiology* / Q000209:etiology* / Q000517:prevention & control; D035843:Biomedical Research / Q000639:trends*; D002681:China / Q000453:epidemiology; D006801:Humans; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors
keywords: China; asthma; research; review